Topic 2 : What Does the Future of Preclinical Tumour Modelling Look Like To You?

Time: 11:42 am
day: Conference Day Two


• How can we use preclinical models to streamline drug development and make it more cost-effective?

• Highlighting the importance of optimizing translatability into the clinic – the next steps

• How can models be used in the context of precision oncology?